✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Hester Biosciences Ltd.

HESTERBIO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹1,857 Cr.
P/E
49.40

Hester Biosciences Ltd.

  • Hester Biosciences
  • SMS Pharmaceuticals
  • Bajaj Healthcare
  • TJI Pharma - Small Cap
FAQs on Hester Biosciences Ltd. Shareprice

Hester Biosciences has given lower returns compared to its competitors.
Hester Biosciences has grown at ~8.03% over the last 7yrs while peers have grown at a median rate of 17.68%

Hester Biosciences is not expensive.
Latest PE of Hester Biosciences is 49.4, while 3 year average PE is 60.71.
Also latest EV/EBITDA of Hester Biosciences is 31.07 while 3yr average is 33.44.

View FAQ's On Business
Growth Table
  • Hester Biosciences Ltd.
  • SMS Pharmaceuticals
  • Bajaj Healthcare
Balance Sheet
  • Hester Biosciences Ltd.
  • SMS Pharmaceuticals
  • Bajaj Healthcare
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Hester Biosciences Ltd.
  • SMS Pharmaceuticals
  • Bajaj Healthcare
Cash Flow
  • Hester Biosciences Ltd.
  • SMS Pharmaceuticals
  • Bajaj Healthcare
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Hester Biosciences Ltd.
  • SMS Pharmaceuticals
  • Bajaj Healthcare
Quarterly Results
  • Hester Biosciences Ltd.
  • SMS Pharmaceuticals
  • Bajaj Healthcare
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Hester Biosciences Ltd. Financials

Balance sheet of Hester Biosciences is strong.
But short term working capital might become an issue for this company.

The net debt of Hester Biosciences is decreasing.
Latest net debt of Hester Biosciences is ₹194 Crs as of Mar-25.
This is less than Mar-24 when it was ₹210 Crs.

Yes, profit is increasing.
The profit of Hester Biosciences is ₹34.35 Crs for TTM, ₹27.49 Crs for Mar 2025 and ₹18.89 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hester Biosciences latest dividend payout ratio is 21.66% and 3yr average dividend payout ratio is 24.75%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech